Kursinformationen zu Manulife Global Fund - Healthcare Fund AA (SGD) Acc

Manulife Global Fund - Healthcare Fund AA (SGD) Acc
Valor 126436308
12.56SGD-0.02SGD-0.15%
29.09.2026
Kursdaten29.09.2026
NAV in CHF
12.56
Tagesveränderung relativ
-0.15%
Tagesveränderung absolut
-0.02
NAV Vortag
12.58
Letzter Handel
29.09.2026
Konditionen
Ausgabekommissionen
+5.00%
Verwaltungsgebühr
+1.50%
OGC
1.62 %
Dokumente
Monatsbericht
-
Halbjahresbericht
-
Jahresbericht
-
Vollständiger Fondsprospekt
-
Gesetzl. Publikationen
-
Fondsstrategie

Healthcare Fund aims to provide medium to long term capital growth for those who hold a long term investment view and who are prepared to accept significant fluctuations in the value of their investments in order to achieve long term returns. It is intended that the investments will be made on a diversified basis. The underlying investment portfolio will mainly consist of equity and equity related securities of companies in health care and related industries globally and which are listed on any stock exchange. The Sub-Fund may invest in companies which derive a significant portion of their earnings from medical and pharmaceutical products and services. The remaining assets of the Sub-Fund may include bonds and deposits. The Healthcare Fund will invest at least 80% of its net assets in equity and equity related securities of health sciences companies. These companies will derive more than half of their revenues from health care-related business activities or commit more than half of their assets to these activities. Such equity and equity related securities include common stocks, preferred stocks and depositary receipts.

Kursentwicklung / Kennzahlen
ZeitraumPerformanceVolatilitätSharpe RatioBester MonatSchlecht. MonatMax Verlust
YTD+3.59%+15.06%+0.15%+6.30%-5.81%-10.22%
6 Monate+7.99%+15.41%+0.91%+6.30%-5.81%-6.23%
1 Jahr+20.73%+14.46%+1.25%+9.70%-5.81%-10.22%
3 Jahre---+9.70%-6.36%-
5 Jahre------
Stammdaten
ISIN
LU2468319715
Valor
126436308
Währung
SGD
Fondstyp
Aktienfonds
Ertragsart
thesaurierend
Anlageschwerpunkt
Branche Gesundheit/Pharma
Anlageregion
weltweit
Domizil
-
Vertriebszulassung
Luxemburg
Auflagedatum
11.04.2023
Fondsvolumen
515'570'709.16
Geschäftsjahresbeginn
01.07.2026
Benchmark
-
Fondsgesellschaft
Manulife IM
Grösste Positionen
Eli Lilly and Company
9.26 %
Johnson & Johnson
6.64 %
AstraZeneca PLC
6.22 %
AbbVie, Inc.
5.62 %
Amgen Inc.
4.72 %
Medtronic Plc
4.71 %
Stryker Corporation
4.27 %
McKesson Corporation
4.26 %
Roche Holding Ltd Dividend Right Cert.
3.85 %
Thermo Fisher Scientific Inc.
3.12 %
Fondszusammensetzung nach Branchen
Pharmazeutika Produktion
38.70 %
Gesundheitswesen
20.70 %
Pharmazeutika/Biotechnologie
20.22 %
Medizinische Produkte/Instrumente
18.76 %
Barmittel und sonst. VM
1.62 %